A current exposure is not a news summary and not a fixed product. It is an observable shift with a researchable decision environment and a defined route into ICG work.
ICG Health Sciences · Active Exposure
For global biopharma companies, the immediate field is the China-side supply of differentiated therapeutic assets: which programs matter, where they sit, and how early they can be identified. ICG examines the field and tests differentiation, evidence, sponsor capability, rights availability, and transaction timing before formal licensing activity makes the opportunity set obvious.
Examine the Exposure
ICG Consulting · Active Exposure
Aging installed assets require longer support while maintenance labor, parts, and repair capacity remain constrained. Sensor-rich retrofits and intelligent new systems are moving intervention from fixed schedules and historical averages toward real-time condition, predicted failure, and remaining useful life.
Examine the Exposure
ICG Engineering · Active Exposure
For power-intensive production, data infrastructure, electrification, and major capital programs, connection timing, available capacity, network reinforcement, and power quality can govern site feasibility before conventional location and design assumptions are fixed.
Examine the Exposure